Main Article Content
atopic dermatitis, infant, TARC, vitamin D, objective SCORAD
Background: Several markers that influence the clinical course of atopic dermatitis (AD) have been investigated so far. Thymus and activation regulated chemokine (TARC) – a Th2-related cytokine – increase in various atopic diseases. It has been shown that vitamin D affects Treg cells and immune responses. Zinc as an essential trace element for cell–cell interactions, cellular differentiation, and proliferation. However, the effect of these markers on infantile AD and disease severity are mostly unknown.
Objective: The aim of this study was to investigate the relationship between TARC, vitamin D, zinc levels, and the disease severity in infants with AD.
Method: AD patients (n = 160) with age and sex that matched healthy controls (n = 79) were included in the study. The diagnosis of AD was made based on the Hanifin–Rajka criteria. The objective SCORAD index was used for the assessment of disease severity.
Results: A total of 160 patients (male 71.9%) with AD were included in the study. The median age of onset of symptoms was 2 (1.0–3.5) months. The lesions initially started on face 76.9%, neck 6.9%, extremities 7.5%, and body 8.8%. Nearly 40% of the patients were found to be atopic. Food allergy was found in 39.4%. The median of objective SCORAD index was 27.5 (17.5–40) in the study group. The TARC levels of AD patients were higher than control group [1803 pg/ml (1006– 3123) vs 709 pg/ml (504–1147), p < 0.001] There was a significant correlation between objective SCORAD scores and TARC values in subjects with AD (r = 0.363, p < 0.001). As the severity of AD increased, vitamin D levels decreased (p for trend 0.015) and TARC values increased (p for trend < 0.001). Serum zinc levels did not change with the severity of the disease. The presence of atopy did not have an influence on serum TARC, zinc, and vitamin D levels.
Conclusion: In infants with AD, disease severity is positively related with TARC levels; and inversely proportional to vitamin D levels. TARC levels differ between patients and healthy controls. The presence of atopy has not been shown to affect these markers.
2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22. https://doi.org/10.1016/S0140-6736(15) 00149-X
3. Gur Cetinkaya P, Sahiner UM. Childhood atopic dermatitis: Current developments, treatment approaches, and future expectations. Turkish J Med Sci. 2019;49(4):963–84. https://doi.org/10.3906/sag-1810-105
4. Thijs J, Krastev T, Weidinger S, Buckens CF, de Bruin-Weller M, Bruijnzeel-Koomen C, et al. Biomarkers for atopic dermatitis: A systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015;15(5):453–60. https://doi.org/10.1097/ ACI.0000000000000198
5. Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22(2):125–37. https://doi.org/10.5021/ad.2010.22.2.125
6. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001;107(3):535–41. https://doi.org/10.1067/mai.2001.113237
7. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Investig Dermatol. 2000;115(4):640–6. https://doi.org/10.1046/j.1523-1747.2000.00115.x
8. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermati-tis. J Allergy Clin Immunol. 2004;113(2):334–40.
9. Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol. 2018;31(2):74– 86. https://doi.org/10.1159/000485132
10. Palmer DJ. Vitamin D and the development of atopic eczema. J Clin Med. 2015;4(5):1036–50. https://doi.org/10.3390/ jcm4051036
11. Thuesen BH, Heede NG, Tang L, Skaaby T, Thyssen JP, Friedrich N, et al. No association between vitamin D and atopy, asthma, lung function or atopic dermatitis: A prospective study in adults. Allergy. 2015;70(11):1501–4. https://doi.org/10.1111/all.12704
12. Kim MJ, Kim SN, Lee YW, Choe YB, Ahn KJ. Vitamin D sta-tus and efficacy of vitamin D supplementation in atopic dermatitis: A systematic review and meta-analysis. Nutrients. 2016;8(12):789. https://doi.org/10.3390/nu8120789
13. Wang SS, Hon KL, Kong AP, Pong HN, Wong GW, Leung TF. Vitamin D deficiency is associated with diagnosis and sever-ity of childhood atopic dermatitis. Pediatr Allergy Immunol. 2014;25(1):30–5. https://doi.org/10.1111/pai.12167
14. David TJ, Wells FE, Sharpe TC, Gibbs AC. Low serum zinc in children with atopic eczema. Br J Dermatol. 1984;111(5):597– 601. https://doi.org/10.1111/j.1365-2133.1984.tb06630.x
15. Gholizadeh N, Mehdipour M, Najafi S, Bahramian A, Garjani S, Khoeini Poorfar H. Evaluation of the serum zinc level in erosive and non-erosive oral lichen planus. J Dentistry. 2014;15(2):52–6.
16. Hanifin JM. Diagnostic criteria for atopic dermatitis: Consider the context. Arch Dermatol. 1999;135(12):1551. https://doi.org/10.1001/archderm.135.12.1551
17. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157(4):645–8. https://doi.org/10.1111/j.1365-2133.2007.08112.x
18. Kahveci M, Koken G, Sahiner UM, Soyer O, Sekerel BE. Immunoglobulin E-mediated food allergies differ in east Mediterranean children aged 0-2 years. Int Arch Allergy Immunol. 2020;181(5):365–74. https://doi.org/10.1159/ 000505996
19. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al. Allergy diagnostic testing: An updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(Suppl 3): S1–148. https://doi.org/10.1016/S1081-1206(10)60305-5
20. Gronhagen C, Liden C, Wahlgren CF, Ballardini N, Bergstrom A, Kull I, et al. Hand eczema and atopic dermatitis in adoles-cents: A prospective cohort study from the BAMSE project. Br J Dermatol. 2015;173(5):1175–82. https://doi.org/10.1111/ bjd.14019
21. Holm JG, Agner T, Clausen ML, Thomsen SF. Determinants of disease severity among patients with atopic dermatitis: Association with components of the atopic march. Arch Dermatol Res. 2019;311(3):173–82. https://doi.org/10.1007/s00403-019-01895-z
22. Gu CY, Gu L, Dou X. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis. Int J Dermatol. 2015;54(7):e261–5. https:// doi.org/10.1111/ijd.12830
23. Garcia C, El-Qutob D, Martorell A, Febrer I, Rodriguez M, Cerda JC, et al. Sensitization in early age to food allergens in children with atopic dermatitis. Allergol Immunopathol. 2007;35(1):15–20. https://doi.org/10.1157/13099090
24. Akan A, Azkur D, Civelek E, Erkocoglu M, Yilmaz-Oztorun Z, Kaya A, et al. Risk factors of severe atopic dermatitis in childhood: Single-center experience. Turkish J Pediatr. 2014;56(2):121–6.
25. Uysal P, Birtekocak F, Karul AB. The relationship between serum TARC, TSLP and POSTN levels and childhood atopic dermatitis. Clin Lab. 2017;63(7):1071–7. https://doi.org/10.7754/ Clin.Lab.2017.161107
26. Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: Correlations with laboratory variables. The British Journal of Dermatology. 2006;155(4):778-83.
27. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2004;15(1):86-8.
28. Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, et al. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis? International Journal of Dermatology. 2007;46(12):1258-62.
29. Borzutzky A, Camargo CA, Jr. Role of vitamin D in the pathogenesis and treatment of atopic dermatitis. Expert Review of Clinical Immunology. 2013;9(8):751-60.
30. Huang CM, Lara-Corrales I, Pope E. Effects of Vitamin D Levels and supplementation on atopic dermatitis: A systematic review. Pediatric Dermatology. 2018;35(6):754-60.
31. Gray NA, Dhana A, Stein DJ, Khumalo NP. Zinc and atopic dermatitis: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology: JEADV. 2019;33(6):1042-–50. https://doi.org/10.1111/jdv.15524
32. Thorsteinsdottir S, Stokholm J, Thyssen JP, Norgaard S, Thorsen J, Chawes BL, et al. Genetic, clinical, and environmental factors associated with persistent atopic dermatitis in childhood. JAMA Dermatol. 2019;155(1):50–7. https://doi.org/10.1001/jamadermatol.2018.4061